Literature DB >> 24425839

A new biometric tool for three-dimensional subcutaneous tumor scanning in mice.

Guido Bocci1, Franco Buffa, Bastianina Canu, Raimondo Concu, Anna Fioravanti, Paola Orlandi, Tonino Pisanu.   

Abstract

AIM: To propose an innovative methodology for the monitoring of the evolution of induced subcutaneous tumors in mice.
MATERIALS AND METHODS: A new 3D scanner able to measure the tumor mass volume is presented. The scanner is based on the projection of a fringe pattern onto the sample surface (structured light). The lines are diffused by the sample and then collected by a digital camera. The obtained 2D-image is treated by the scanner's software that extracts the 3D information and evaluates the sample volume.
RESULTS: The 3D scanner has been successfully used in the measurement of subcutaneous HT-29 colorectal cancer xenografts treated with 5-fluorouracil, bevacizumab and their combination. Comparison with simple caliper measurements revealed important and significant differences between the two measurement techniques.
CONCLUSION: The proposed methodology is more effective than the usual approach based on caliper measurements.

Entities:  

Keywords:  3D scanner; Biometry; colorectal cancer; subcutaneous tumor measurements

Mesh:

Substances:

Year:  2014        PMID: 24425839

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

1.  An innovative non-invasive technique for subcutaneous tumour measurements.

Authors:  Juan Delgado-SanMartin; Beate Ehrhardt; Marcin Paczkowski; Sean Hackett; Andrew Smith; Wajahat Waraich; James Klatzow; Adeala Zabair; Anna Chabokdast; Leonardo Rubio-Navarro; Amar Rahi; Zena Wilson
Journal:  PLoS One       Date:  2019-10-14       Impact factor: 3.240

2.  Characterization of prostate cancer cell progression in zebrafish xenograft model.

Authors:  Wei Xu; Brittany A Foster; Mackenzie Richards; Kenneth R Bondioli; Girish Shah; Christopher C Green
Journal:  Int J Oncol       Date:  2017-11-06       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.